RxDoctor Payments Data

Richard Wilson, DO

Family Medicine · Estero, FLNPI 1528021417

Payments from drug & device makers

$2,758in general payments, 2019–2025

Across 152 payments — averaging $18.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Incyte Corporation$351
  • Almatica Pharma LLC$239
  • Lilly USA, LLC$235
  • AstraZeneca$235
  • Novo Nordisk$143
  • plus $418 from 10 others

What the payments were for

  • Food & beverage$2,66397%
  • Education$953%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,758 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$250,817
Medicare patients
322
Services billed
1,935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$30,923
OzempicSemaglutide19$30,399
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$22,684
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl51$6,968
JanumetSitagliptin Phos/Metformin Hcl13$5,803
Saxagliptin-Metformin ErSaxagliptin Hcl/Metformin Hcl11$2,022
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen73$1,569
Metoprolol Succinate61$1,270
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine62$1,250
Alprazolam123$1,152
Albuterol Sulfate HfaAlbuterol Sulfate43$1,112
Gabapentin42$924
Levothyroxine Sodium81$882
Tamsulosin Hcl36$872
Atorvastatin Calcium96$802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$38$30,92331 claims
Novo NordiskOzempic$143$30,39919 claims
GSKTrelegy Ellipta$1,138$22,68432 claims
Almatica Pharma LLCSertraline Hcl$239$32746 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Estero

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →